Eric has over 30 years of clinical research experience. He started his career in 1983 as head trial department of the Comprehensive Cancer Center Amsterdam. Between 1990 and 2000 he has held several positions at companies specialized in electronic data collection systems for clinical research as well as market research for the pharmaceutical industry. In 2000 he joined NDDO Oncology, a spin-off company of the EORTC, where he acted as COO and CEO. After acquisition of NDDO Oncology by INC Research in 2005 Eric became Vice President Oncology for Europe of INC Research. Eric is one of the co-founders of SMS-oncology, a specialized oncology CRO established in 2007 where he worked as COO and CEO. In 2013 he became partner of Aglaia.
ISA Pharmaceuticals’ Chief Scientific Officer Prof. Cornelis Melief Receives ESMO Immuno-Oncology Award 2018
Dr. Axel Mescheder appointed CEO of Cristal Therapeutics as focus intensifies on proprietary oncology nanomedicine pipeline